Genovis Enters Licensing and Supply Agreement with New Bioprocess Customer
We have signed a long-term licensing and supply agreement with a new bioprocess customer!
The new partner will initially use our SmartEnzyme™ for the preclinical process development and up-scaling of the manufacturing process to support the regulatory submission to enable further clinical development. The ultimate goal is to generate a platform of novel therapeutic molecules to bring a series of new treatments to patients!
Read more in the press release.